Zenabis Gets Green Light To Sell Cannabis Oil Produced At N.B. Facility
ATHOLVILLE – Canadian medicinal and recreational cannabis producer Zenabis will be adding a new product to their offerings.
The company announced Monday that it has the license to now sell cannabis oil produced at its Atholville facility, one of the largest indoor cannabis growing facilities in Canada. Zenabis was already processing oil at the facility.
Zenabis expects to market and sell cannabis oil products to its medical clients and to adult recreational consumers through supply and distribution agreements that Zenabis has in place with nine Canadian jurisdictions including British Columbia, Alberta, Saskatchewan, Quebec, Nova Scotia, New Brunswick, Manitoba, Prince Edward Island, and the Yukon.
Cannabis oil products may be sold as oral drops or sprays, or in soft gel capsules, providing consumers with a convenient, controlled and discrete dose.
“This approval provides us with the ability to serve new and existing customers with an expanded range of adult use and medical products through new and easy to use consumption methods. This product category is incredibly important for Zenabis, as it supports our overall growth and product leadership strategy,” said Andrew Grieve, CEO of Zenabis.
“Ingestion of cannabis oil tends to offer a longer lasting effect than vaping or smoking dried cannabis, providing medical clients and adult use consumers with a broader set of options in Zenabis products. We look forward to bringing our cannabis oil products to market and continuing to innovate and expand our product offerings.”
“In addition, with this update to our Atholville processing license, we now have the capacity to develop a variety of additional value-added cannabis oil products, and cannabis extract products consistent with the proposed amendments to the Cannabis Regulations that allow for greater product diversity.”
Zenabis expects to have its initial cannabis oil products available for sale in both the medical and adult use markets by early Q2, 2019, and will be launching additional formats and formulations throughout the year.